BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 8274387)

  • 21. Botulinum A toxin treatment in spasmodic torticollis: report of 56 patients.
    Poungvarin N; Viriyavejakul A
    J Med Assoc Thai; 1994 Sep; 77(9):464-70. PubMed ID: 7706965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
    Tan AK
    Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A; Decq P; Filipetti P; Kéravel Y
    Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
    Whitaker J; Butler A; Semlyen JK; Barnes MP
    Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin treatment in clinical neurology.
    Van den Bergh P
    Acta Neurol Belg; 1995; 95(2):70-9. PubMed ID: 7618431
    [No Abstract]   [Full Text] [Related]  

  • 27. [Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients].
    Novis SA; De Mattos JP; De Rosso AL
    Arq Neuropsiquiatr; 1995 Sep; 53(3-A):403-10. PubMed ID: 8540813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
    Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE
    Adv Neurol; 1988; 50():599-608. PubMed ID: 3400513
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of focal dystonia with botulinic toxin].
    Gracia F; Castillo LC
    Rev Med Panama; 1996 Sep; 21(3):121-31. PubMed ID: 9280925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin therapy.
    Savino PJ; Maus M
    Neurol Clin; 1991 Feb; 9(1):205-24. PubMed ID: 2011110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of botulinum toxin in physical medicine and rehabilitation.
    Cuevas-Trisán RL; Cruz-Jiménez M
    Bol Asoc Med P R; 2006; 98(1):42-55. PubMed ID: 19610549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
    Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
    Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical use of botulinum toxin].
    Jost WH
    Nervenarzt; 2008 Jun; 79 Suppl 1():9-14. PubMed ID: 18927958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of spasticity with botulinum toxin: a double-blind study.
    Snow BJ; Tsui JK; Bhatt MH; Varelas M; Hashimoto SA; Calne DB
    Ann Neurol; 1990 Oct; 28(4):512-5. PubMed ID: 2252363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin in otolaryngology: a review of its actions and opportunities for use.
    Neuenschwander MC; Pribitkin EA; Sataloff RT
    Ear Nose Throat J; 2000 Oct; 79(10):788-9, 792, 794 passim. PubMed ID: 11055100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait.
    O'Brien CF
    Adv Neurol; 2001; 87():265-9. PubMed ID: 11347231
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of botulinum neurotoxin for spasticity].
    Mukai Y; Kaji R
    Brain Nerve; 2008 Dec; 60(12):1421-6. PubMed ID: 19110753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interventional neuropediatrics: treatment of dystonic and spastic muscular hyperactivity with botulinum toxin A.
    Heinen F; Wissel J; Philipsen A; Mall V; Leititis JU; Schenkel A; Stücker R; Korinthenberg R
    Neuropediatrics; 1997 Dec; 28(6):307-13. PubMed ID: 9453027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of focal dystonia with botulinum toxin].
    Nagamine T; Kaji R; Hamano T; Kimura J
    Rinsho Shinkeigaku; 1991 Jan; 31(1):32-7. PubMed ID: 2044303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.